KYTX Stock Analysis: Buy, Sell, or Hold?
KYTX - Kyverna Therapeutics, Inc. Common Stock
$8.01
-0.20 (-2.44%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When KYTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called KYTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: KYTX is down 17.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: KYTX is down 17.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: KYTX is currently trading at $8.01, which is considered oversold relative to its 30-day fair value range of $8.23 to $9.44.
Technical Outlook: Technically, KYTX is in a strong uptrend. Immediate support is located at $7.67, while resistance sits at $10.55.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.60 (+260.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KYTX is in a strong uptrend. Immediate support is located at $7.67, while resistance sits at $10.55.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.60 (+260.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$8.23 -
$9.44
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding KYTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 260.5% below Wall St target ($29.60)
- WARNING: Recommendation downgraded due to -17.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$8.23 -
$9.44
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$7.67
Resistance Level
$10.55
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.41
Wall Street Target
$29.60
(+260.5%)
Last updated: January 31, 2026 2:09 AM ET
Data refreshes hourly during market hours. Next update: 3:09 AM
Data refreshes hourly during market hours. Next update: 3:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KYTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced KYTX Option Strategies
Professional options setups generated by AI based on today's KYTX price and gamma walls.
